{"id":7958,"date":"2026-05-14T12:01:47","date_gmt":"2026-05-14T09:01:47","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=7958"},"modified":"2026-05-14T12:35:58","modified_gmt":"2026-05-14T09:35:58","slug":"hfcas12max-in-crispr-based-therapeutics-crispr-guidex-tool","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/hfcas12max-in-crispr-based-therapeutics-crispr-guidex-tool\/","title":{"rendered":"CRISPR GuideX Arac\u0131: CRISPR Bazl\u0131 Tedavilerde hfCas12Max"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Yeni nesil CRISPR tabanl\u0131 terapilere olan ilgi artmaya devam ederken, hfCas12Max ve geli\u015fmi\u015f gen d\u00fczenleme stratejisi platformlar\u0131 gibi yenilik\u00e7i ara\u00e7lar bilim camias\u0131nda giderek daha fazla ilgi \u00e7ekiyor. Taiwo Afolabi (Arda Bora Yigit arac\u0131l\u0131\u011f\u0131yla) DMDWarrior&#039;a ula\u015farak, hfCas12Max sistemini kullanarak gen d\u00fczenleme stratejilerini haritalamak i\u00e7in geli\u015ftirdi\u011fi CRISPR GuideX platformunu tan\u0131tt\u0131.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Yaz\u0131l\u0131m m\u00fchendisi ve hesaplamal\u0131 biyolog olan ve \u015fu anda Obafemi Awolowo \u00dcniversitesi&#039;nde (OAU) Mikrobiyoloji alan\u0131nda e\u011fitimini tamamlayan Afolabi, y\u00fcksek performansl\u0131 biyoinformatik ara\u00e7lar\u0131 geli\u015ftirmeye odaklan\u0131yor. Ayr\u0131ca CRISPR GuideX&#039;nin ba\u011f\u0131ms\u0131z bir proje oldu\u011funu ve \u00fcniversiteyle ba\u011flant\u0131l\u0131 olmad\u0131\u011f\u0131n\u0131 veya \u00fcniversite taraf\u0131ndan finanse edilmedi\u011fini vurgulad\u0131.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne Musk\u00fcler Distrofisi tedavilerinde h\u0131zl\u0131 geli\u015fmeler devam ederken, Taiwo Afolabi taraf\u0131ndan geli\u015ftirilen hfCas12Max arac\u0131 ve CRISPR GuideX gibi yeni nesil CRISPR tabanl\u0131 teknolojiler, daha hassas ve etkili genetik terapilerin geli\u015ftirilmesini h\u0131zland\u0131rma potansiyelleri nedeniyle giderek daha fazla ilgi \u00e7ekmektedir. Bu yenilik\u00e7i ara\u00e7lar, ara\u015ft\u0131rmac\u0131lar\u0131n daha g\u00fcvenli gen d\u00fczenleme stratejileri tasarlamalar\u0131na, hedefleme do\u011frulu\u011funu art\u0131rmalar\u0131na ve DMD&#039;de ki\u015fiselle\u015ftirilmi\u015f tedavi yakla\u015f\u0131mlar\u0131 i\u00e7in olanaklar\u0131 geni\u015fletmelerine yard\u0131mc\u0131 olabilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu makalede, hfCas12Max&#039;in Duchenne kas distrofisi toplulu\u011funa nas\u0131l fayda sa\u011flayabilece\u011fini, ara\u015ft\u0131rmac\u0131lar\u0131n terap\u00f6tik potansiyeli konusunda neden heyecanl\u0131 olduklar\u0131n\u0131 ve CRISPR GuideX platformunun gen d\u00fczenleme geli\u015ftirme s\u00fcrecini nas\u0131l basitle\u015ftirip h\u0131zland\u0131rabilece\u011fini inceleyece\u011fiz.<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#what-is-hf-cas-12-max-in-crispr-based-therapeutics\">CRISPR tabanl\u0131 terap\u00f6tiklerde hfCas12Max nedir?<\/a><\/li><li><a href=\"#what-are-the-key-differences-between-hf-cas-12-max-cas-9-and-cas-12-a\">hfCas12Max, Cas9 ve Cas12a aras\u0131ndaki temel farklar nelerdir?<\/a><\/li><li><a href=\"#how-important-is-hf-cas-12-max-in-the-development-of-treatments-for-duchenne-muscular-dystrophy\">Duchenne kas distrofisi tedavilerinin geli\u015ftirilmesinde hfCas12Max&#039;in \u00f6nemi ne kadar b\u00fcy\u00fckt\u00fcr?<\/a><ul><\/ul><\/li><li><a href=\"#interview-understanding-crispr-guide-x-and-hf-cas-12-max-for-duchenne-muscular-dystrophy\">R\u00f6portaj: Duchenne Kas Distrofisi \u0130\u00e7in CRISPR GuideX ve hfCas12Max&#039;\u0131 Anlamak<\/a><ul><li><a href=\"#q-could-you-briefly-introduce-yourself\">Taiwo Afolabi kimdir?<\/a><\/li><li><a href=\"#q-what-is-crispr-guide-x\">CRISPR GuideX nedir?<\/a><\/li><li><a href=\"#q-what-inspired-you-to-develop-crispr-guide-x\">CRISPR GuideX&#039;yi geli\u015ftirme konusunda size ilham veren neydi?<\/a><\/li><li><a href=\"#q-what-is-hf-cas-12-max-and-how-does-it-differ-from-cas-9-or-cas-12-a\">hfCas12Max nedir ve Cas9 veya Cas12a&#039;dan fark\u0131 nedir?<\/a><\/li><li><a href=\"#q-can-you-explain-the-exon-2-example-in-dmd\">DMD'deki ekzon 2 \u00f6rne\u011fini a\u00e7\u0131klayabilir misiniz?<\/a><\/li><li><a href=\"#q-what-about-patients-with-exon-42-43-deletions\">Peki ya \u00f6rne\u011fin 42-43. ekzon delesyonu olan hastalar?<\/a><\/li><li><a href=\"#q-do-pharmaceutical-companies-already-use-mapping-systems-like-crispr-guide-x\">\u0130la\u00e7 \u015firketleri halihaz\u0131rda CRISPR GuideX gibi haritalama sistemlerini kullan\u0131yor mu?<\/a><\/li><li><a href=\"#q-have-you-discussed-crispr-guide-x-with-pharmaceutical-companies\">CRISPR GuideX&#039;yi ila\u00e7 \u015firketleriyle g\u00f6r\u00fc\u015ft\u00fcn\u00fcz m\u00fc?<\/a><\/li><li><a href=\"#q-will-crispr-guide-x-remain-free-in-the-future\">CRISPR GuideX gelecekte de \u00fccretsiz kalacak m\u0131?<\/a><\/li><li><a href=\"#what-is-the-next-step\">Sonraki ad\u0131m nedir?<\/a><\/li><li><a href=\"#how-can-researchers-and-crispr-based-drug-developers-contact-taiwo-afolabi\">Ara\u015ft\u0131rmac\u0131lar ve CRISPR Bazl\u0131 \u0130la\u00e7 Geli\u015ftiricileri Taiwo Afolabi ile Nas\u0131l \u0130leti\u015fime Ge\u00e7ebilir?<\/a><\/li><\/ul><\/li><li><a href=\"#final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-is-hf-cas-12-max-in-crispr-based-therapeutics\">CRISPR tabanl\u0131 terap\u00f6tiklerde hfCas12Max nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">hfCas12Max, genetik tedavileri daha g\u00fcvenli ve etkili hale getirmek i\u00e7in tasarlanm\u0131\u015f daha yeni ve daha geli\u015fmi\u015f bir CRISPR gen d\u00fczenleme arac\u0131d\u0131r. Di\u011fer CRISPR sistemleri gibi, zararl\u0131 mutasyonlar\u0131 onarmak i\u00e7in DNA&#039;y\u0131 belirli noktalarda kesebilen &quot;molek\u00fcler makas&quot; gibi \u00e7al\u0131\u015f\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">hfCas12Max&#039;\u0131 \u00f6nemli k\u0131lan \u015fey, insan tedavileri i\u00e7in \u00f6zel olarak tasarlanm\u0131\u015f olmas\u0131d\u0131r. Daha k\u00fc\u00e7\u00fck, daha hassas ve eski CRISPR ara\u00e7lar\u0131na k\u0131yasla daha az istenmeyen DNA de\u011fi\u015fikli\u011fine neden olabilir. Kompakt boyutu sayesinde, gen terapisinde yayg\u0131n olarak kullan\u0131lan AAV vir\u00fcsleri gibi da\u011f\u0131t\u0131m sistemlerine daha kolay s\u0131\u011fabilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bilim insanlar\u0131, Duchenne kas distrofisi ve tek bir tedaviyle uzun s\u00fcreli genetik d\u00fczeltmenin m\u00fcmk\u00fcn olabilece\u011fi di\u011fer kal\u0131tsal bozukluklar gibi hastal\u0131klar i\u00e7in hfCas12Max&#039;\u0131 inceliyorlar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-are-the-key-differences-between-hf-cas-12-max-cas-9-and-cas-12-a\">hfCas12Max, Cas9 ve Cas12a aras\u0131ndaki temel farklar nelerdir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u00dc\u00e7\u00fc de genleri d\u00fczenlemek i\u00e7in kullan\u0131lan CRISPR ara\u00e7lar\u0131d\u0131r, ancak farkl\u0131 g\u00fc\u00e7l\u00fc ve zay\u0131f y\u00f6nleri vard\u0131r.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u00d6zellik<\/th><th>Cas9<\/th><th>Cas12a<\/th><th>hfCas12Max<\/th><\/tr><\/thead><tbody><tr><td>Boyut<\/td><td>Daha b\u00fcy\u00fck<\/td><td>Orta<\/td><td>Daha k\u00fc\u00e7\u00fck<\/td><\/tr><tr><td>Kesinlik<\/td><td>\u0130yi<\/td><td>Daha iyi<\/td><td>\u00c7ok y\u00fcksek<\/td><\/tr><tr><td>V\u00fccuda teslimat<\/td><td>Daha zor<\/td><td>Orta<\/td><td>Daha kolay<\/td><\/tr><tr><td>DNA hedefleme esnekli\u011fi<\/td><td>S\u0131n\u0131rl\u0131<\/td><td>Daha iyi<\/td><td>En geni\u015f<\/td><\/tr><tr><td>\u0130stenmeyen d\u00fczenlemeler riski<\/td><td>Daha y\u00fcksek<\/td><td>Daha d\u00fc\u015f\u00fck<\/td><td>En d\u00fc\u015f\u00fck<\/td><\/tr><tr><td>Terapi ama\u00e7l\u0131 \u00f6zel olarak tasarlanm\u0131\u015ft\u0131r.<\/td><td>K\u0131smen<\/td><td>K\u0131smen<\/td><td>Evet<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Basit\u00e7e ifade etmek gerekirse:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cas9, en \u00fcnl\u00fc ve yayg\u0131n olarak kullan\u0131lan ara\u00e7t\u0131r, ancak daha b\u00fcy\u00fckt\u00fcr ve bazen yanl\u0131\u015f DNA b\u00f6lgelerini d\u00fczenleyebilir.<\/strong><\/li>\n\n\n\n<li>Cas12a bu sorunlar\u0131n baz\u0131lar\u0131n\u0131 iyile\u015ftirdi ve genomun daha fazla b\u00f6lgesini hedefleyebiliyor.<\/li>\n\n\n\n<li><strong>hfCas12Max, gelecekteki gen terapileri i\u00e7in daha k\u00fc\u00e7\u00fck, daha g\u00fcvenli ve daha esnek olacak \u015fekilde tasarlanm\u0131\u015f, daha yeni ve y\u00fcksek do\u011fruluklu bir versiyondur.<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok ara\u015ft\u0131rmac\u0131, hfCas12Max&#039;in \u015fu \u00f6zellikleri bir araya getirmesi nedeniyle \u00f6nemli bir yeni nesil CRISPR sistemi haline gelebilece\u011fine inan\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>g\u00fc\u00e7l\u00fc d\u00fczenleme yetene\u011fi,<\/li>\n\n\n\n<li>hedef d\u0131\u015f\u0131 riskleri azaltmak,<\/li>\n\n\n\n<li>ve insan h\u00fccrelerine daha kolay iletim.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu durum, \u00f6zellikle kas rahats\u0131zl\u0131klar\u0131 gibi v\u00fccudun tamam\u0131n\u0131 kapsayan tedavi gerektiren hastal\u0131klar i\u00e7in son derece \u00f6nemlidir.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"864\" height=\"1821\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic.png\" alt=\"hfCas12Max, Cas9 ve Cas12a teknolojileri aras\u0131ndaki temel farklar\u0131 g\u00f6steren dikey CRISPR bilgi grafi\u011fi.\" class=\"wp-image-7961\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic.png 864w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-142x300.png 142w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-486x1024.png 486w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-768x1619.png 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-729x1536.png 729w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-6x12.png 6w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-199x420.png 199w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-150x316.png 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-300x632.png 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/crispr-hfcas12max-infographic-696x1467.png 696w\" sizes=\"auto, (max-width: 864px) 100vw, 864px\" \/><figcaption class=\"wp-element-caption\">CRISPR temelli Duchenne kas distrofisi tedavileri i\u00e7in hfCas12Max, Cas9 ve Cas12a&#039;y\u0131 kar\u015f\u0131la\u015ft\u0131ran bilgi grafi\u011fi.<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-important-is-hf-cas-12-max-in-the-development-of-treatments-for-duchenne-muscular-dystrophy\">Duchenne kas distrofisi tedavilerinin geli\u015ftirilmesinde hfCas12Max&#039;in \u00f6nemi ne kadar b\u00fcy\u00fckt\u00fcr?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">hfCas12Max, gen d\u00fczenleme terapilerinin g\u00fcvenli\u011fini ve hassasiyetini art\u0131rmak i\u00e7in tasarlanm\u0131\u015f yeni nesil bir CRISPR arac\u0131d\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"why-does-it-matter-for-dmd\">DMD i\u00e7in neden \u00f6nemli?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi, distrofin genindeki mutasyonlardan kaynaklan\u0131r. hfCas12Max, bilim insanlar\u0131n\u0131n bu mutasyonlar\u0131 daha etkili bir \u015fekilde onarmas\u0131na yard\u0131mc\u0131 olabilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"key-advantages\">Ba\u015fl\u0131ca Avantajlar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Eski CRISPR sistemlerine k\u0131yasla, hfCas12Max \u015fu \u00f6zelliklere sahiptir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Daha k\u00fc\u00e7\u00fck ve kas h\u00fccrelerine iletilmesi daha kolay<\/li>\n\n\n\n<li>Daha az istenmeyen DNA d\u00fczenlemesiyle daha hassas<\/li>\n\n\n\n<li>Farkl\u0131 mutasyonlar\u0131 hedeflemede daha esnek<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"future-potential\">Gelecek Potansiyeli<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok ara\u015ft\u0131rmac\u0131, hfCas12Max&#039;in DMD i\u00e7in gelecekteki tek seferlik genetik tedavilerde \u00f6nemli bir rol oynayabilece\u011fine inan\u0131yor, ancak daha fazla klinik ara\u015ft\u0131rmaya hala ihtiya\u00e7 var.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"interview-understanding-crispr-guide-x-and-hf-cas-12-max-for-duchenne-muscular-dystrophy\">R\u00f6portaj: Duchenne Kas Distrofisi \u0130\u00e7in CRISPR GuideX ve hfCas12Max&#039;\u0131 Anlamak<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Yeni nesil CRISPR tabanl\u0131 tedavilere olan ilgi artmaya devam ederken, hfCas12Max ve CRISPR GuideX gibi yenilik\u00e7i ara\u00e7lar Duchenne kas distrofisi toplulu\u011funda giderek daha fazla ilgi \u00e7ekiyor. DMDWarrior okuyucular\u0131n\u0131n bu teknolojileri ve genetik tedavileri h\u0131zland\u0131rmadaki potansiyel rollerini daha iyi anlamalar\u0131na yard\u0131mc\u0131 olmak i\u00e7in, CRISPR GuideX&#039;nin geli\u015ftiricisi olan Taiwo Afolabi ile g\u00f6r\u00fc\u015ft\u00fck.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-could-you-briefly-introduce-yourself\">Taiwo Afolabi kimdir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Benim ad\u0131m Taiwo Afolabi. Y\u00fcksek performansl\u0131 biyoinformatik ara\u00e7lar\u0131 geli\u015ftirmeye odaklanm\u0131\u015f bir yaz\u0131l\u0131m m\u00fchendisi ve hesaplamal\u0131 biyolo\u011fum. \u015eu anda Obafemi Awolowo \u00dcniversitesi&#039;nde (OAU) Mikrobiyoloji b\u00f6l\u00fcm\u00fcnde \u00f6\u011frenimimi tamaml\u0131yorum. Akademik ge\u00e7mi\u015fim ara\u015ft\u0131rmalar\u0131m\u0131 \u015fekillendirse de, CRISPR GuideX ba\u011f\u0131ms\u0131z bir projedir ve \u00fcniversiteyle ba\u011flant\u0131l\u0131 veya \u00fcniversite taraf\u0131ndan finanse edilmemektedir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-what-is-crispr-guide-x\">CRISPR GuideX nedir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR GuideX v3.1, tamamen \u00f6zg\u00fcn ve ba\u011f\u0131ms\u0131z olarak geli\u015ftirilmi\u015f bir gen d\u00fczenleme strateji platformudur. Yaz\u0131l\u0131m mimarisi, kullan\u0131c\u0131 aray\u00fcz\u00fc ve kaynak kodu tamamen s\u0131f\u0131rdan tasarlanm\u0131\u015ft\u0131r. \u015eu anda patentli olmamas\u0131na ra\u011fmen, tescilli ba\u011f\u0131ms\u0131z bir platform olarak faaliyet g\u00f6stermektedir. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/taiwoafolabi.shinyapps.io\/crispr-app\/\" target=\"_blank\" rel=\"noreferrer noopener\">CRISPR GuideX&#039;ye Daha Yak\u0131ndan Bak\u0131n<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-what-inspired-you-to-develop-crispr-guide-x\">CRISPR GuideX&#039;yi geli\u015ftirme konusunda size ilham veren neydi?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bu alanda b\u00fcy\u00fck bir eksiklik fark ettim. Mevcut gen d\u00fczenleme ara\u00e7lar\u0131n\u0131n \u00e7o\u011fu yava\u015f, a\u015f\u0131r\u0131 teknik veya ara\u015ft\u0131rmac\u0131lar\u0131 yava\u015flatan eski aray\u00fczlere dayan\u0131yor. Amac\u0131m, h\u0131zl\u0131 ve g\u00f6rsel olarak sezgisel bir platform olu\u015fturmak i\u00e7in modern web geli\u015ftirmeyi geli\u015fmi\u015f genomikle birle\u015ftirmekti. Ayr\u0131ca, genellikle CRISPR tabanl\u0131 klinik \u00e7al\u0131\u015fma tasar\u0131mlar\u0131n\u0131 s\u0131n\u0131rlayan PAM k\u0131s\u0131tlamalar\u0131n\u0131 da ele almak istedim.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-what-is-hf-cas-12-max-and-how-does-it-differ-from-cas-9-or-cas-12-a\">hfCas12Max nedir ve Cas9 veya Cas12a&#039;dan fark\u0131 nedir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR enzimleri molek\u00fcler makas gibi \u00e7al\u0131\u015f\u0131r, ancak DNA&#039;y\u0131 rastgele kesemezler. \u00d6ncelikle PAM ad\u0131 verilen belirli bir ba\u011flanma dizisini tan\u0131malar\u0131 gerekir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Standart Cas9, &quot;NGG&quot; PAM dizisi gerektirirken, Cas12a daha k\u0131s\u0131tlay\u0131c\u0131 bir &quot;TTTV&quot; dizisi gerektirir. Ancak hfCas12Max, \u00e7ok daha esnek bir &quot;TN&quot; veya &quot;TNN&quot; PAM dizisine ihtiya\u00e7 duyar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu esneklik, hfCas12Max&#039;in genom i\u00e7indeki potansiyel d\u00fczenleme b\u00f6lgelerinin say\u0131s\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rmas\u0131na olanak tan\u0131r. Baz\u0131 durumlarda, hastan\u0131n mutasyonu standart bir PAM b\u00f6lgesini bozarsa, hfCas12Max yine de yak\u0131ndaki alternatif bir hedef b\u00f6lge belirleyebilir ve b\u00f6ylece tedavi stratejisini koruyabilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-can-you-explain-the-exon-2-example-in-dmd\">DMD'deki ekzon 2 \u00f6rne\u011fini a\u00e7\u0131klayabilir misiniz?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Elbette. Sim\u00fclasyonumuzda, ekzon kayb\u0131 olarak da bilinen \u00e7oklu ekzon silme stratejisini modelledik. Bu yakla\u015f\u0131m, ekzon 2 i\u00e7indeki k\u00fc\u00e7\u00fck bir mutasyonu do\u011frudan d\u00fczeltmek yerine, \u00e7evresindeki intronik b\u00f6lgeleri hedefleyerek ekzon 2&#039;yi tamamen ortadan kald\u0131rmak i\u00e7in iki k\u0131lavuz RNA kullan\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00fczenlemeden sonra, v\u00fccut ekzon 1'i do\u011frudan ekzon 3'e ekler. Bu teknik olarak \u00e7er\u00e7eve d\u0131\u015f\u0131 bir transkript olu\u015fturmas\u0131na ra\u011fmen, DMD geni benzersiz bir biyolojik yedekleme mekanizmas\u0131 i\u00e7erir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ara\u015ft\u0131rmalar, bu spesifik ekzon 1-ekzon 3 birle\u015fim noktas\u0131n\u0131n, ekzon 5'te bulunan bir \u0130\u00e7 Ribozom Giri\u015f B\u00f6lgesi'ni (IRES) aktive etti\u011fini g\u00f6stermi\u015ftir. Bu mekanizma, ribozomun bozulmu\u015f okuma \u00e7er\u00e7evesini atlamas\u0131na ve protein \u00fcretimini ekzon 6'dan yeniden ba\u015flatmas\u0131na olanak tan\u0131yarak i\u015flevsel, k\u0131salt\u0131lm\u0131\u015f bir distrofin proteini olu\u015fmas\u0131n\u0131 sa\u011flar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GuideX, ara\u015ft\u0131rmac\u0131lar\u0131n hfCas12Max kullanarak bu s\u00fcreci ger\u00e7ekle\u015ftirmek i\u00e7in gereken en g\u00fcvenli ve en verimli intronik kesme s\u0131n\u0131rlar\u0131n\u0131 belirlemelerine yard\u0131mc\u0131 olur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-what-about-patients-with-exon-42-43-deletions\">Peki ya \u00f6rne\u011fin 42-43. ekzon delesyonu olan hastalar?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">42 ve 43. ekzonlar\u0131 eksik olan hastalarda okuma \u00e7er\u00e7evesi bozulur. 44. ekzonun hassas bir \u015fekilde \u00e7\u0131kar\u0131lmas\u0131yla, h\u00fccre 41. ekzonu do\u011frudan 45. ekzona yeniden ba\u011flayabilir ve okuma \u00e7er\u00e7evesini geri y\u00fckleyebilir. Bu, DMD i\u00e7in ekzon atlama terapilerinin temel kavramlar\u0131ndan biridir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-do-pharmaceutical-companies-already-use-mapping-systems-like-crispr-guide-x\">\u0130la\u00e7 \u015firketleri halihaz\u0131rda CRISPR GuideX gibi haritalama sistemlerini kullan\u0131yor mu?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Kesinlikle. CRISPR terapileri geli\u015ftiren \u015firketler zaten b\u00fcy\u00fck \u00f6l\u00e7\u00fcde haritalama sistemlerine g\u00fcveniyor. Bununla birlikte, mevcut platformlar\u0131n \u00e7o\u011fu b\u00fcy\u00fck hesaplama altyap\u0131lar\u0131, geli\u015fmi\u015f kodlama uzmanl\u0131\u011f\u0131 ve uzun i\u015flem s\u00fcreleri gerektiriyor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR GuideX, eri\u015filebilirlik ve h\u0131za odaklanmaktad\u0131r. Son derece d\u00fc\u015f\u00fck gecikmeyle do\u011frudan taray\u0131c\u0131da sim\u00fclasyonlar ger\u00e7ekle\u015ftirebilen, y\u00fcksek d\u00fczeyde optimize edilmi\u015f algoritmalar kullan\u0131r. Platform ayr\u0131ca dinamik g\u00f6rsel sim\u00fclasyonlar ve \u00f6zellikle hfCas12Max i\u00e7in optimize edilmi\u015f \u00f6zel filtreler i\u00e7erir. Daha Fazla Bilgi Edinin: <a href=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/05\/CRISPR_GuideX_v3.1_Expanded_Technical_Brief.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">CRISPR GuideX v3.1<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-have-you-discussed-crispr-guide-x-with-pharmaceutical-companies\">CRISPR GuideX&#039;yi ila\u00e7 \u015firketleriyle g\u00f6r\u00fc\u015ft\u00fcn\u00fcz m\u00fc?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u015eu anda tan\u0131t\u0131m \u00e7al\u0131\u015fmalar\u0131n\u0131n erken a\u015famalar\u0131nday\u0131z. A\u011f\u0131m arac\u0131l\u0131\u011f\u0131yla, GuideX&#039;i ger\u00e7ek d\u00fcnya klinik i\u015f ak\u0131\u015flar\u0131na entegre etme konusunda geri bildirim toplamak amac\u0131yla gen d\u00fczenleme alan\u0131ndaki ara\u015ft\u0131rmac\u0131lar ve y\u00f6neticilerle g\u00f6r\u00fc\u015fmelere ba\u015flad\u0131k.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"q-will-crispr-guide-x-remain-free-in-the-future\">CRISPR GuideX gelecekte de \u00fccretsiz kalacak m\u0131?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u015eu anda GuideX, e\u011fitim ama\u00e7l\u0131 ve ara\u015ft\u0131rma do\u011frulamas\u0131 i\u00e7in \u00fccretsiz olarak eri\u015filebilir durumdad\u0131r. Gelecekte, ticarile\u015ftirme, kurumsal lisanslama ve biyoteknoloji \u015firketleriyle ortakl\u0131klara a\u00e7\u0131\u011f\u0131m.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-is-the-next-step\">Sonraki ad\u0131m nedir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Unutmamak gerekir ki bu, bilgisayarlarda yap\u0131lan bir hesaplama at\u0131l\u0131m\u0131d\u0131r, yar\u0131n klinikte kullan\u0131ma haz\u0131r bir ila\u00e7 de\u011fildir. Doktorlar\u0131n ve bilim insanlar\u0131n\u0131n laboratuvarda y\u0131llarca deneme yan\u0131lma yaparak zaman kaybetmemeleri i\u00e7in, bulmacay\u0131 sanal ortamda \u00e7\u00f6zmek i\u00e7in geli\u015fmi\u015f yaz\u0131l\u0131mlar kullan\u0131yoruz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">hfCas12Max'in bilgisayar ortam\u0131nda Ekzon 2'yi g\u00fcvenli ve etkili bir \u015fekilde hedefleyebildi\u011fini kan\u0131tlayarak, laboratuvar bilim insanlar\u0131 i\u00e7in temiz bir \"hazine haritas\u0131\" sa\u011flad\u0131k. Bir sonraki ad\u0131m, laboratuvarlar\u0131n bu bilgisayar taraf\u0131ndan olu\u015fturulan k\u0131lavuzlar\u0131 al\u0131p petri kab\u0131ndaki insan h\u00fccrelerinde test etmesidir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu yeni nesil teknoloji konusunda son derece umutluyuz ve bu tedavileri bilgisayar ortam\u0131ndan ger\u00e7ek d\u00fcnyaya daha h\u0131zl\u0131 bir \u015fekilde ta\u015f\u0131maya yard\u0131mc\u0131 olacak yaz\u0131l\u0131mlar\u0131 geli\u015ftirmeye devam edece\u011fiz.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"how-can-researchers-and-crispr-based-drug-developers-contact-taiwo-afolabi\">Ara\u015ft\u0131rmac\u0131lar ve CRISPR Bazl\u0131 \u0130la\u00e7 Geli\u015ftiricileri Taiwo Afolabi ile Nas\u0131l \u0130leti\u015fime Ge\u00e7ebilir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR GuideX, hfCas12Max tabanl\u0131 gen d\u00fczenleme stratejileri veya potansiyel bilimsel i\u015f birlikleri hakk\u0131nda daha fazla bilgi edinmek isteyen ara\u015ft\u0131rmac\u0131lar, biyoteknoloji \u015firketleri ve CRISPR tabanl\u0131 terap\u00f6tik geli\u015ftiriciler, a\u015fa\u011f\u0131da verilen ileti\u015fim kanallar\u0131 arac\u0131l\u0131\u011f\u0131yla do\u011frudan Taiwo Afolabi ile ileti\u015fime ge\u00e7ebilirler. Platform hakk\u0131nda ek teknik bilgi, klinik \u00f6ncesi strateji haritalamas\u0131 veya gelecekteki geli\u015ftirme f\u0131rsatlar\u0131 arayanlar, daha fazla g\u00f6r\u00fc\u015fme i\u00e7in ileti\u015fime ge\u00e7meye te\u015fvik edilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">E-posta: <a href=\"mailto:taiwoglory136@gmail.com\">taiwoglory136@gmail.com<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">LinkedIn: <a href=\"https:\/\/www.linkedin.com\/in\/taiwo-afolabi-b5b827227\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.linkedin.com\/in\/taiwo-afolabi-b5b827227\/<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">hfCas12Max ve CRISPR GuideX, Duchenne Musk\u00fcler Distrofisi i\u00e7in CRISPR tabanl\u0131 tedavilerde umut vadeden bir ilerlemeyi temsil etmektedir. Bu teknolojiler, ara\u015ft\u0131rmac\u0131lar\u0131n daha g\u00fcvenli ve daha hassas gen d\u00fczenleme stratejileri tasarlamalar\u0131na yard\u0131mc\u0131 olabilir. Esneklikleri, farkl\u0131 mutasyonlar i\u00e7in distrofin restorasyon yakla\u015f\u0131mlar\u0131n\u0131 iyile\u015ftirebilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR GuideX ayr\u0131ca bilim insanlar\u0131 i\u00e7in daha h\u0131zl\u0131 ve daha eri\u015filebilir strateji haritalamas\u0131 sunmaktad\u0131r. Daha fazla klinik ara\u015ft\u0131rmaya ihtiya\u00e7 duyulmas\u0131na ra\u011fmen, hfCas12Max&#039;e olan erken ilgi artmaya devam etmektedir. Bir\u00e7ok uzman, yeni nesil CRISPR ara\u00e7lar\u0131n\u0131n gelecekteki DMD tedavilerini d\u00f6n\u00fc\u015ft\u00fcrebilece\u011fine inanmaktad\u0131r. Daha h\u0131zl\u0131 geli\u015ftirme s\u00fcre\u00e7leri de terap\u00f6tik ke\u015fifleri h\u0131zland\u0131rabilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi toplulu\u011fu bu geli\u015fmeleri yak\u0131ndan takip etmeye devam ediyor. CRISPR GuideX gibi yenilik\u00e7i platformlar gelecekteki ara\u015ft\u0131rmalarda \u00f6nemli bir rol oynayabilir. DMD i\u00e7in hassas gen d\u00fczenlemesinin gelece\u011fi giderek daha umut verici g\u00f6r\u00fcn\u00fcyor.<\/p>","protected":false},"excerpt":{"rendered":"<p>As interest in next-generation CRISPR-based therapies continues to grow, innovative tools such as hfCas12Max and advanced gene-editing strategy platforms are attracting increasing attention within the scientific community. Taiwo Afolabi reached out (via Arda Bora Yigit) to DMDWarrior to introduce CRISPR GuideX, a platform he developed for mapping gene-editing strategies using the hfCas12Max system. Afolabi, a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7964,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[778,777,290,773,774,776,772,775],"class_list":["post-7958","post","type-post","status-publish","format-standard","has-post-thumbnail","category-editorials","tag-cas12a","tag-cas9","tag-crispr","tag-crispr-gene-editing-tool","tag-crispr-guidex","tag-crispr-based-therapies","tag-hfcas12max","tag-taiwo-afolabi"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=7958"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7958\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/7964"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=7958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=7958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=7958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}